Idexx Laboratories (IDXX) Lags Q2 Earnings Estimates
Idexx Laboratories (IDXX) came out with quarterly earnings of $2.44 per share, missing the Zacks Consensus Estimate of $2.87 per share. This compares to earnings of $2.67 per share a year ago.
Looking For Fast Growth In Healthcare? IDEXX Has You Covered
IDEXX Laboratories is a $41 billion market cap giant in the diagnostics and research industry, with shares falling 13% since February. The company specializes in animal healthcare diagnostics, show...
IDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds
IDEXX's (IDXX) supply chain operations bear the brunt of geopolitical instability, including the current war in Ukraine.
IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Finan...
Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
Fortune.com recently reported that artificial intelligence (AI) is helping the pet care industry cope with a chronic veterinary shortage. AI use cases could become far more prevalent for pets than ...
IDEXX (IDXX) Q1 Earnings Surpass Estimates, 2024 View Slashed
IDEXX (IDXX) delivers better-than-expected earnings in the first quarter of 2024.
Idexx Laboratories (IDXX) Tops Q1 Earnings Estimates
Idexx Laboratories (IDXX) came out with quarterly earnings of $2.81 per share, beating the Zacks Consensus Estimate of $2.68 per share. This compares to earnings of $2.55 per share a year ago.
IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar
IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the animal diagnostic equipment maker expects a hit from a slowdown in veterinary clinic visi...
Seeking Clues to Idexx (IDXX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Idexx (IDXX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the q...
What Lies Ahead of IDEXX Laboratories (IDXX) in Q1 Earnings?
IDEXX Laboratories' (IDXX) first-quarter 2024 results are likely to reflect the benefits of strong execution against the growth strategy.
Idexx Laboratories (IDXX) Beats Stock Market Upswing: What Investors Need to Know
Idexx Laboratories (IDXX) concluded the recent trading session at $519.81, signifying a +0.99% move from its prior day's close.
All You Need to Know About Idexx (IDXX) Rating Upgrade to Buy
Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain IDEXX (IDXX) Stock for Now
IDEXX Laboratories, Inc. IDXX is likely to grow in the coming quarters, backed by the sustained success of CAG's recurring diagnostic products and services. The company's international business per...
IDEXX's (IDXX) Global Growth Continues, Currency Woes Persist
A key element of IDEXX's (IDXX) customer engagement strategy is the expansion of its commercial footprint in a disciplined approach.
Related Companies